Navigation Links
Spectranetics Introduces New Device for Removal of Non-Functional and Infected Cardiac Leads
Date:5/15/2008

LLD EZ(TM) Provides Physicians with Flexibility and Control for Lead

Removal

COLORADO SPRINGS, Colo., May 15 /PRNewswire-FirstCall/ -- Spectranetics Corporation (Nasdaq: SPNC) today announced the availability of the new LLD EZ Lead Locking Device (LLD) for the removal of non-functional or infected pacing and defibrillation leads. The LLD EZ enables physicians to secure the entire lead creating traction to enable the removal process.

Management of implanted leads for pacemakers and defibrillators is a growing concern among physicians and patients since an increasing number of patients receive these devices at a relatively young age. Leads, or insulated wires that connect devices to the heart, may become non-functional or infected. When this occurs the primary treatment option is to remove the leads. Because scar tissue can bind the leads in several places along their length, specialized tools are needed to complete the removal process.

Spectranetics' LLD EZ provides a flexible solution to address the removal of leads from scar tissue holding them in place. LLD EZ employs a braided mesh that expands to secure leads along their hollow inner lumen permitting physicians to apply steady traction on the lead. The locking mechanism can be reversed, or unlocked, if the physician needs to remove the device from the lead or reposition it. The LLD EZ provides versatility to remove a wide range of pacing and defibrillation lead sizes.

"Controlling the entire lead length throughout the removal process is important for achieving safe and complete removal. The LLD technology gives me this control; it's a feature that other tools don't offer," said Dr. Laurence Epstein, Chief of Cardiac Arrhythmia Services, Brigham and Women's Hospital in Boston. "The design of the LLD EZ makes it easy to incorporate this tool into my cases."

LLD EZ also features an enhanced tip design and sleek profile to facilitate tracking and passage of the device through tight curves and beyond lumen damage. The specialized tip is radiopaque, enabling verification of tip location under fluoroscopy. Additionally, a new low-profile handle design permits easy loading of extraction sheaths. Spectranetics' Lead Locking Device technology is often used in conjunction with Spectranetics' Laser Sheath, or SLS II, which employs "cool" ultraviolet light known as excimer laser to dissolve the scar tissue binding the leads.

"Increasingly, lead removal is the best decision for many of my patients when lead issues are encountered. The LLD EZ fits the majority of leads making device selection easy," said Dr. Roger Carrillo, a cardiothoracic surgeon at Mount Sinai Medical Center in Miami. "With the sleek tip design, the LLD EZ simplifies navigation and manipulation."

Spectranetics' LLD EZ is currently available in the United States and Canada and is a variant of the Company's LLD E device, which received clearance from the Food and Drug Administration in March 2005. For additional information or to purchase the LLD EZ, please visit http://www.spectranetics.com.

About Spectranetics

Founded in 1984, Spectranetics manufactures and sells the only excimer laser approved in the United States, Europe and Japan for use in minimally invasive cardiovascular procedures. This technology treats complex cardiovascular conditions by photo-ablating multiple lesion types into tiny particles that are easily absorbed into the blood stream. The Company's disposable catheters use high-energy "cool" ultraviolet light to vaporize arterial blockages in the legs and heart, as well as scar tissue encapsulating pacing and defibrillation leads. For more information, visit http://www.spectranetics.com.

Stacey Holifield/Kate Finigan

Schwartz Communications, Inc.

(781) 684-0770

spectranetics@schwartz-pr.com


'/>"/>
SOURCE Spectranetics Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Spectranetics to Present at The A.G Edwards Growth Conference on September 18
2. Spectranetics to Appeal Decision in Patent Litigation
3. Spectranetics Receives Reimbursement Approval in Belgium for Lead Removal and Peripheral Atherectomy Products
4. Spectranetics to Hold 2007 Third Quarter Financial Results Conference Call on October 31
5. Spectranetics Announces Clinical Data From Cello Trial
6. Delta Dental of Illinois Introduces Smile Smart For Your Health
7. Highmark Blue Cross Blue Shield Introduces New Health Plan Comparison Tool for Consumers
8. Highmark Blue Shield Introduces New Health Plan Comparison Tool for Consumers
9. Sentillion Introduces Affordable Next Generation Healthcare Single Sign-On Solution Called expreSSO(TM)
10. GladRags Introduces the Moon Cup - An Environmentally-Sound and Safe Alternative to Disposable Feminine Hygiene Products!
11. Triveris Introduces Personal Health Record with Built-in Health Advisor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... PA (PRWEB) , ... December 02, 2016 , ... With ... struggling through rehabilitation of an injury, patients must find the one that works for ... his pain, he created a machine that worked and decided to share it with ...
(Date:12/2/2016)... Hills, CA (PRWEB) , ... December 02, 2016 ... ... reconstructive surgeon in Beverly Hills, California, will be included in the 2016 “Guide ... given to exceptional professionals based on the amalgamation of their education, experience, and ...
(Date:12/2/2016)... ... ... Mediaplanet is proud to announce the launch of its ... therapeutic technologies, and revolutionized nutrition that are helping patients and physicians manage their ... the last 3 decades,” says Dr. Valentine Fuster, a world-renowned cardiologist. “This is ...
(Date:12/2/2016)... ... December 02, 2016 , ... The PAINWeekEnd Regional ... Resort and Spa in Honolulu, offering local frontline clinicians the opportunity to extend ... , The demand for supplemental training related to pain management has surged dramatically ...
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... Sourced from ... has some unique properties including its unmatched natural purity of just 6 ppm TDS ... and crisp. , Nothing Water has been available in several ShopRite and FoodTown stores ...
Breaking Medicine News(10 mins):
(Date:12/4/2016)...   Pairnomix, LLC, a genetic research company and ... the White House, today announced that findings from its first ... candidate therapies for a patient with epileptic encephalopathy caused by ... at the 70 th Annual Meeting of the ... , December 2-6, 2016.  Pairnomix, unique process involves ...
(Date:12/4/2016)... EAST HANOVER, N.J. , Dec. 3, 2016 /PRNewswire/ ... SEG101 (crizanlizumab, formerly SelG1), an anti-P-selectin antibody, reduced the ... by 45.3% compared to placebo (1.63 vs 2.98, p=0.010) ... Novartis today announced that the data are being featured ... American Society of Hematology (ASH) Annual Meeting and ...
(Date:12/4/2016)... Dec. 3, 2016  Findings from a Novartis ... CTL019, an investigational chimeric antigen receptor T cell ... young adult patients with B-cell acute lymphoblastic leukemia ... session at the 58th American Society of Hematology ... p.m.). The global Phase II study found that ...
Breaking Medicine Technology: